Yahoo
Swiss CHF

Medacta Group SA (MOVE.SW)

117.60 -3.40 (-2.81%)
At close: October 30 at 5:30:30 PM GMT+1
Chart Range Bar
Loading chart for MOVE.SW
  • Previous Close 121.00
  • Open 121.60
  • Bid --
  • Ask --
  • Day's Range 118.00 - 121.60
  • 52 Week Range 107.40 - 177.20
  • Volume 77,059
  • Avg. Volume 29,955
  • Market Cap (intraday) 2.346B
  • Beta (5Y Monthly) 1.01
  • PE Ratio (TTM) 32.85
  • EPS (TTM) 3.58
  • Earnings Date Sep 9, 2026
  • Forward Dividend & Yield 1.10 (0.94%)
  • Ex-Dividend Date May 7, 2026
  • 1y Target Est 153.33

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.

www.medacta.com

2,273

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

MOVE.SW
24.23%
MSCI WORLD (^990100-USD-STRD)
9.06%

1-Year Return

MOVE.SW
18.94%
MSCI WORLD (^990100-USD-STRD)
9.89%

3-Year Return

MOVE.SW
18.24%
MSCI WORLD (^990100-USD-STRD)
0.00%

5-Year Return

MOVE.SW
21.52%
MSCI WORLD (^990100-USD-STRD)
53.16%

Analyst Insights

View More

Analyst Price Targets

118.04
153.33 Average
117.60 Current
175.63 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    10.92%

  • Return on Assets (ttm)

    7.19%

  • Return on Equity (ttm)

    17.03%

  • Revenue (ttm)

    707.85M

  • Net Income Avi to Common (ttm)

    77.28M

  • Diluted EPS (ttm)

    3.58

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    35.99M

  • Total Debt/Equity (mrq)

    66.36%

  • Levered Free Cash Flow (ttm)

    -50.49M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: